Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
17.45
Dollar change
+0.20
Percentage change
1.16
%
IndexRUT P/E- EPS (ttm)-2.75 Insider Own7.87% Shs Outstand90.28M Perf Week2.77%
Market Cap1.61B Forward P/E- EPS next Y-2.38 Insider Trans-0.55% Shs Float83.82M Perf Month5.44%
Income-258.08M PEG- EPS next Q-0.73 Inst Own98.70% Short Float13.74% Perf Quarter-7.92%
Sales0.00M P/S- EPS this Y3.63% Inst Trans-0.79% Short Ratio13.98 Perf Half Y-23.20%
Book/sh3.62 P/B4.82 EPS next Y15.32% ROA-52.01% Short Interest11.52M Perf Year-10.83%
Cash/sh2.56 P/C6.83 EPS next 5Y41.70% ROE-59.27% 52W Range15.98 - 32.53 Perf YTD-41.78%
Dividend Est.- P/FCF- EPS past 5Y-9.09% ROI-73.20% 52W High-46.35% Beta1.06
Dividend TTM- Quick Ratio6.05 Sales past 5Y0.00% Gross Margin- 52W Low9.23% ATR (14)0.85
Dividend Ex-Date- Current Ratio6.05 EPS Y/Y TTM16.29% Oper. Margin0.00% RSI (14)49.56 Volatility5.69% 4.54%
Employees268 Debt/Eq0.08 Sales Y/Y TTM- Profit Margin- Recom1.12 Target Price46.93
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q5.41% Payout- Rel Volume1.10 Prev Close17.25
Sales Surprise- EPS Surprise5.37% Sales Q/Q- EarningsNov 07 AMC Avg Volume823.68K Price17.45
SMA200.35% SMA50-3.24% SMA200-22.58% Trades Volume902,588 Change1.16%
Date Action Analyst Rating Change Price Target Change
Oct-16-24Initiated Scotiabank Sector Outperform
Apr-02-24Initiated Goldman Neutral $39
Oct-24-23Initiated Cantor Fitzgerald Overweight $65
Feb-01-23Initiated Morgan Stanley Overweight $45
Nov-08-22Initiated Canaccord Genuity Buy $53
Nov-01-22Initiated BTIG Research Buy $35
Jul-08-22Initiated Raymond James Outperform $22
Oct-20-21Resumed Cowen Outperform
Mar-02-21Initiated Stifel Buy $64
Feb-18-21Initiated Needham Buy $75
Nov-08-24 07:00AM
Nov-07-24 04:01PM
Sep-17-24 07:00AM
Sep-10-24 07:00AM
Aug-27-24 07:00AM
09:06AM Loading…
Aug-25-24 09:06AM
Aug-05-24 09:55PM
04:01PM
Jun-28-24 12:30PM
07:27AM
Jun-05-24 11:30AM
May-29-24 07:00AM
May-10-24 06:00AM
May-07-24 11:26AM
May-06-24 09:55PM
04:01PM Loading…
04:01PM
Apr-30-24 12:00PM
Apr-24-24 11:33AM
07:39AM
Apr-03-24 11:32AM
Apr-02-24 06:00AM
Mar-27-24 11:30AM
Mar-26-24 04:01PM
Feb-27-24 12:20PM
Feb-26-24 04:01PM
Feb-13-24 07:00AM
Jan-22-24 03:39AM
Jan-04-24 11:55AM
Jan-02-24 04:01PM
Dec-12-23 07:00AM
12:16PM Loading…
Nov-23-23 12:16PM
Nov-15-23 11:17AM
Nov-09-23 09:55AM
Nov-06-23 04:15PM
04:04PM
Nov-05-23 07:30AM
Nov-02-23 06:26PM
Oct-27-23 02:49PM
Oct-20-23 03:18AM
Oct-19-23 07:00AM
Oct-02-23 07:00AM
Sep-26-23 04:01PM
Sep-23-23 09:45AM
Sep-18-23 07:30AM
Sep-15-23 11:00AM
Sep-14-23 10:12AM
Sep-13-23 04:34PM
01:50PM
01:36PM
12:30PM
12:23PM
12:15PM
11:56AM
10:54AM
07:24AM
12:01AM
Sep-12-23 04:02PM
04:01PM
Sep-06-23 04:05PM
Aug-10-23 07:14AM
07:00AM
Jul-29-23 11:39AM
Jul-28-23 03:57PM
Jun-12-23 04:34PM
Jun-09-23 09:24AM
Jun-08-23 07:00AM
May-31-23 07:00AM
May-23-23 07:00AM
May-19-23 06:00AM
May-18-23 06:12AM
May-17-23 04:26PM
May-09-23 07:00AM
May-04-23 04:21PM
04:01PM
May-03-23 04:01PM
Apr-11-23 04:01PM
Apr-04-23 04:01PM
Mar-01-23 04:01PM
Feb-27-23 04:01PM
Feb-09-23 04:01PM
Feb-07-23 07:00AM
Feb-05-23 09:07AM
Jan-28-23 01:30PM
Jan-23-23 10:15AM
09:55AM
Jan-09-23 04:01PM
Jan-06-23 09:55AM
Jan-03-23 04:01PM
Dec-22-22 06:00AM
Dec-12-22 10:00AM
Dec-11-22 07:21PM
Dec-01-22 04:01PM
Nov-21-22 08:00AM
Nov-16-22 07:59AM
Nov-03-22 04:01PM
09:00AM
Oct-27-22 09:55AM
Oct-14-22 06:35PM
Oct-12-22 06:00AM
Oct-11-22 09:55AM
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
White Mark AndrewSee RemarksOct 31 '24Sale16.623,08051,20569,140Nov 04 04:06 PM
Militello JohnSee RemarksOct 31 '24Sale16.6291715,24550,534Nov 04 04:05 PM
Militello JohnOfficerOct 31 '24Proposed Sale16.6291715,245Oct 31 03:34 PM
White Mark AndrewOfficerOct 31 '24Proposed Sale16.623,08051,205Oct 31 03:24 PM
Militello JohnSee RemarksAug 16 '24Sale18.501,06419,68851,451Aug 20 04:26 PM
Patel KinnariSee RemarksAug 16 '24Sale18.503,98973,812396,983Aug 20 04:26 PM
Shah GauravCEOAug 16 '24Sale18.509,650178,564718,419Aug 20 04:26 PM
Wilson MartinGeneral CounselAug 16 '24Sale18.501,02719,00464,735Aug 20 04:26 PM
Militello JohnOfficerAug 16 '24Proposed Sale18.501,06419,688Aug 16 03:39 PM
Patel KinnariOfficerAug 16 '24Proposed Sale18.503,98973,810Aug 16 03:29 PM
Wilson MartinOfficerAug 16 '24Proposed Sale18.501,02719,003Aug 16 03:23 PM
Shah GauravOfficerAug 16 '24Proposed Sale18.509,650178,559Aug 16 03:16 PM
Militello JohnSee RemarksJul 22 '24Sale23.0281218,68852,515Jul 24 04:05 PM
White Mark AndrewSee RemarksJul 08 '24Sale20.393,02661,71572,220Jul 09 04:05 PM
Militello JohnSee RemarksMay 16 '24Sale23.351,07925,19553,327May 20 04:36 PM
Shah GauravCEOMay 14 '24Option Exercise0.0017,6620646,134May 20 04:33 PM
Shah GauravCEOMay 16 '24Sale23.359,790228,596728,069May 20 04:33 PM
Wilson MartinGeneral CounselMay 14 '24Option Exercise0.002,420021,100May 20 04:29 PM
Wilson MartinGeneral CounselMay 16 '24Sale23.351,04824,47165,762May 20 04:29 PM
Patel KinnariSee RemarksMay 14 '24Option Exercise0.009,5430301,824May 20 04:26 PM
Patel KinnariSee RemarksMay 16 '24Sale23.354,04694,474400,972May 20 04:26 PM
Militello JohnSee RemarksApr 22 '24Sale22.8783319,05154,406Apr 24 04:06 PM
SOUTHWELL DAVID PDirectorApr 12 '24Option Exercise4.3470,000303,940165,160Apr 16 05:45 PM
SOUTHWELL DAVID PDirectorApr 15 '24Option Exercise4.3429,624128,627124,784Apr 16 05:45 PM
SOUTHWELL DAVID PDirectorApr 12 '24Sale24.3670,0001,705,26595,160Apr 16 05:45 PM
SOUTHWELL DAVID PDirectorApr 15 '24Sale24.0510,000240,520114,784Apr 16 05:45 PM
White Mark AndrewSee RemarksApr 08 '24Sale24.6412,532308,76375,226Apr 10 08:39 PM
Makker GothamDirectorMar 21 '24Sale28.43274,0007,790,943365,912Mar 25 08:58 PM
Militello JohnSee RemarksMar 21 '24Sale28.102,49069,97955,239Mar 25 08:54 PM
Militello JohnSee RemarksFeb 29 '24Option Exercise12.5510,000125,50031,517Mar 04 06:54 PM
Militello JohnSee RemarksFeb 29 '24Sale29.8410,000298,45021,517Mar 04 06:54 PM
Wilson MartinGeneral CounselFeb 29 '24Sale29.334,100120,25718,680Mar 04 06:48 PM
Wilson MartinGeneral CounselFeb 16 '24Sale29.843,576106,7016,136Feb 21 08:54 PM
Patel KinnariSee RemarksFeb 16 '24Sale29.847,132212,805238,346Feb 21 08:54 PM
Militello JohnSee RemarksFeb 16 '24Sale29.843,23896,61513,195Feb 21 08:54 PM
Shah GauravCEOFeb 16 '24Sale29.8420,272604,876554,762Feb 21 08:54 PM
Patel KinnariSee RemarksFeb 14 '24Option Exercise0.0026,1890245,478Feb 16 04:05 PM
Militello JohnSee RemarksFeb 14 '24Option Exercise0.006,274016,433Feb 16 04:05 PM
Militello JohnSee RemarksJan 22 '24Sale27.2063817,35610,159Jan 23 04:22 PM
Militello JohnSee RemarksJan 18 '24Option Exercise0.001,586010,797Jan 22 04:05 PM
Makker GothamDirectorNov 15 '23Sale22.5320,000450,6461,296,497Nov 16 07:24 PM
Patel KinnariSee RemarksNov 14 '23Option Exercise0.003,9890220,437Nov 16 07:17 PM
Militello JohnSee RemarksNov 14 '23Option Exercise0.0072509,485Nov 16 06:58 PM